Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec:220:121-124.
doi: 10.1016/j.thromres.2022.10.011. Epub 2022 Oct 22.

The homophilic CD84 receptor is upregulated on platelets in COVID-19 and sepsis

Affiliations

The homophilic CD84 receptor is upregulated on platelets in COVID-19 and sepsis

Lukas J Weiss et al. Thromb Res. 2022 Dec.
No abstract available

Keywords: CD84; COVID-19; Platelets; Sepsis; Thrombo-inflammation.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest BN and DS have filed a patent (PCT/EP/2020/068464) related to targeting CD84 as treatment option in ischemic diseases. All other authors do not declare any conflict of interest.

Figures

Fig. 1
Fig. 1
(A) Platelets of patients with sepsis (s) or COVID-19 showed highly increased CD84 surface expression at 4 different time points over the disease (t1 = day of ICU admission; t2 = d4; t3 = d7, t4 = d14). (B) CD84 expression in COVID-19 patients was independent of platelet size indicated by mean platelet volume (MPV) (C-D) CD84 expression was analyzed by immunoblot in lysates of healthy controls and COVID-19 patients. CD84 signal intensity was set in relation to GAPDH. (E-F) CD84 expression on megakaryocytes (day 9) derived from human CD34+ cells upon co-incubation with platelet poor plasma (3 %) from sepsis patients or controls. (G-H) CD84 shedding was observed in COVID-19 patients upon CCCP [100 μM] stimulation for 60 min at 37 °C but not upon TRAP-6 stimulation [5 μM]. Metalloproteinase inhibitor GM6001 [100 μM] prevented CD84 shedding. (I-J) CD84 expression on neutrophils (CD45+/CD15+) or lymphocytes (CD3+/CD8; CD3+/CD8+) was assessed flow cytometrically. (K) Formation of platelet leukocyte-aggregates (PLA: CD41+/CD45+) and CD84 expression were assessed flow cytometrically and the values correlated by calculation of Pearson's r. (L) Platelets of healthy donors were incubated for 2 h at 37 °C in platelet-poor plasma or (M-N) whole blood of allogenous healthy controls or COVID-19 patients prior to measuring platelet CD84 expression flow cytometrically. Representative curves are shown in panel C, E, G, I and M. Scale bars indicate 60 μM in panel E. Data is indicated as median ± 95 % CI. Statistical analysis was performed using (A) Kruskal-Wallis test, (E) paired t-test or (K, L, N) Mann-Whitney test. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.

References

    1. Stegner D., Göb V., Krenzlin V., et al. Foudroyant cerebral venous (sinus) thrombosis triggered through CLEC-2 and GPIIb/IIIa dependent platelet activation. Nature Cardiovascular Research. 2022;1(2):132–141. - PMC - PubMed
    1. Hofmann S., Braun A., Pozgaj R., Morowski M., Vogtle T., Nieswandt B. Mice lacking the SLAM family member CD84 display unaltered platelet function in hemostasis and thrombosis. PLoS One. 2014;9(12) - PMC - PubMed
    1. Hofmann S., Vogtle T., Bender M., Rose-John S., Nieswandt B. The SLAM family member CD84 is regulated by ADAM10 and calpain in platelets. J. Thromb. Haemost. 2012;10(12):2581–2592. - PubMed
    1. Schuhmann M.K., Stoll G., Bieber M., et al. CD84 links T cell and platelet activity in cerebral thrombo-inflammation in acute stroke. Circ. Res. 2020;127(8):1023–1035. - PMC - PubMed
    1. Nicolai L., Leunig A., Brambs S., et al. Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy. Circulation. 2020;142(12):1176–1189. - PMC - PubMed

Substances